Incorporation of obidoxime into human serum albumin nanoparticles: optimisation of preparation parameters for the development of a stable formulation.
about
Recent advancements in erythrocytes, platelets, and albumin as delivery systemsEncapsulating gold nanomaterials into size-controlled human serum albumin nanoparticles for cancer therapy platforms.New structural scaffolds for centrally acting oxime reactivators of phosphylated cholinesterases.Comparison of protein- and polysaccharide-based nanoparticles for cancer therapy: synthesis, characterization, drug release, and interaction with a breast cancer cell line.Role of membrane dynamics processes and exogenous molecules in cellular resveratrol uptake: consequences in bioavailability and activities.Mini review on blood-brain barrier penetration of pyridinium aldoximes.
P2860
Incorporation of obidoxime into human serum albumin nanoparticles: optimisation of preparation parameters for the development of a stable formulation.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Incorporation of obidoxime int ...... pment of a stable formulation.
@en
Incorporation of obidoxime int ...... pment of a stable formulation.
@nl
type
label
Incorporation of obidoxime int ...... pment of a stable formulation.
@en
Incorporation of obidoxime int ...... pment of a stable formulation.
@nl
prefLabel
Incorporation of obidoxime int ...... pment of a stable formulation.
@en
Incorporation of obidoxime int ...... pment of a stable formulation.
@nl
P2860
P1476
Incorporation of obidoxime int ...... pment of a stable formulation.
@en
P2093
Jörg Kreuter
Jürgen Kufleitner
P2860
P304
P356
10.3109/02652048.2010.501395
P577
2010-01-01T00:00:00Z